The U.S. Food and Drug Administration’s vaccine committee has voted that the next wave of COVID booster shots should include a component that targets the Omicron variant of the coronavirus, in addition to the original strain. If all goes well, vaccine manufacturers could roll out these new versions in the U.S. in October.
